Nestlé Skin Health SHIELD Hackathon Inspires Winning Innovations in Skin Health

Hackathon judges award $20,000 in prizes, with a grand prize still up for grabs. 

NEW YORK (March 29, 2017) – Four innovation teams took top prizes at the inaugural Nestlé Skin Health SHIELD Hackathon on March 10th and 11th, 2017. Judges awarded $5,000 to each winning team for their innovative proposals to address challenges in skin health. Next month, the teams are invited to give an extended pitch for the grand prize of $20,000 and a yearlong collaboration residency at the Nestlé Skin Health SHIELD flagship site at the Alexandria Center for Life Sciences in New York City.

The four hackathon winners include:

  • Acne care based on microbiome analysis
  • A game to engage children and teens in skin wellness and hydration
  • A three-in-one skin care regimen delivery system targeting Baby Boomer women
  • A personalized DIY skin care regimen system for today’s eco-conscious consumers

“The Hackathon is the culmination of a six-month digital skin health innovation series that our SHIELD community developed in partnership with the Global Coalition on Aging and Hacking Health New York,” explained Dr. Warren Winkelman, Senior Medical Director and Head of Medical Innovation at SHIELD. “Events like this represent what SHIELD is about: multi-disciplinary and multi-generational collaboration to advance skin wellness through innovation, both low tech and high tech.”

At the hackathon, 22 teams of 77 participants gathered at the Nestlé Skin Health SHIELD Center in New York City for two days, digging into the biggest challenges in skin health, designing solutions, and turning these ideas into competitive business proposals.

“This series has engaged members of the New York digital health community of all ages and all backgrounds on the growing importance of skin health throughout our increasingly long lives. Before they walked in the door at SHIELD, most of the participants had not given much thought to skin health. They walked out on Saturday night inspired to keep dreaming up new ways to empower skin wellness in our age of longevity,” said Melissa Mitchell, Executive Director of the Global Coalition on Aging, who served as a mentor to the teams.

“SHIELD clearly, like us, is part of this movement of people passionate about bringing innovation to healthcare,” said Luc Sirois, Founder of Hacking Health.

SHIELD charged the participants to develop innovative solutions in four challenge areas: Skin Health Literacy, Nutrition and Skin Health, Engaging Acne, and Skin Health Technology for the Aging Population. As the participants developed their business proposals and prepared their 5-minute pitches, they were guided along the way by mentors from within Nestlé Skin Health and from across the SHIELD network who generously shared their expertise. “I was honored to be able to coach these future entrepreneurs to help them prepare their pitches,” said Yvan Deurbroeck, Global VP of Communications for Nestlé Skin Health. “Seeing so much creativity at SHIELD and so many minds set to the task of advancing skin wellness was both inspiring and humbling.”

“We loved participating in the hackathon,” said Tammy Sachs, a member of the winning team in the Technology for the Aging track. “The mentors were incredibly helpful, and everyone was so supportive. We look forward to the next challenge.”

In addition to awarding the four checks, the panel judges – Julia Belaya of Plug and Play Innovation Center, Gurdane Bhutania, cofounder of venture capital firm FundRx; SHIELD Managing Director Didier Leclercq; Nestlé Skin Health Patent Counsel Jessica Mikus; and Jeff Powers, Galderma’s IT Director for Marketing and Commercial Operations – chose to bestow an Honorable Mention and invitation to return to a fifth team for its work developing an open source digital solution to empower developing countries across the globe to better address the burden of skin disease, its complications, and its impact on the health of their at-risk populations.

“We are excited about all of the truly incredible ideas created here at SHIELD this weekend,” said Mr. Leclercq. “And we can’t wait until next month when we will select one of these very talented teams to work with us over the coming year to turn their inspiration into reality.”

About Nestlé Skin Health SHIELD

Nestlé Skin Health SHIELD is a global network of innovation and education hubs gathering today’s most creative and visionary thinkers from diverse disciplines to generate, develop, and incubate ideas to advance skin health for tomorrow. SHIELD explores creative partnerships, new concepts, and technologies to help preserve lifelong skin health; mitigate the emergence of skin conditions; and integrate the skin dimension into the public consciousness, discourses on policy, and the organization of age-friendly spaces. More information at www.nestleskinhealth.com/shield

About the Global Coalition on Aging

GCOA is the world’s leading business voice on aging policy and strategy. GCOA advances policy and market solutions to ensure aging is a path for economic growth, winning business strategies, and social well-being.

About Hacking Health

Hacking Health aims to transform healthcare by connecting healthcare professionals with designers, developers, innovators, and entrepreneurs to build realistic, human-centric solutions to front-line healthcare problems.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.